Bank of New York Mellon’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.46M | Buy |
321,117
+3,091
| +1% | +$52.6K | ﹤0.01% | 2213 |
|
|
2025
Q1 | $6.21M | Buy |
318,026
+41,109
| +15% | +$803K | ﹤0.01% | 2096 |
|
|
2024
Q4 | $6.87M | Buy |
276,917
+49,372
| +22% | +$1.22M | ﹤0.01% | 2118 |
|
|
2024
Q3 | $5.57M | Sell |
227,545
-60,024
| -21% | -$1.47M | ﹤0.01% | 2244 |
|
|
2024
Q2 | $6.74M | Sell |
287,569
-2,319
| -0.8% | -$54.3K | ﹤0.01% | 2173 |
|
|
2024
Q1 | $9.58M | Sell |
289,888
-148,517
| -34% | -$4.91M | ﹤0.01% | 1975 |
|
|
2023
Q4 | $11.9M | Sell |
438,405
-55,511
| -11% | -$1.51M | ﹤0.01% | 1888 |
|
|
2023
Q3 | $11.9M | Buy |
493,916
+12,060
| +3% | +$290K | ﹤0.01% | 1841 |
|
|
2023
Q2 | $15.4M | Buy |
481,856
+5,463
| +1% | +$174K | ﹤0.01% | 1699 |
|
|
2023
Q1 | $14.6M | Sell |
476,393
-16,318
| -3% | -$500K | ﹤0.01% | 1723 |
|
|
2022
Q4 | $19.3M | Sell |
492,711
-9,297
| -2% | -$364K | ﹤0.01% | 1556 |
|
|
2022
Q3 | $23.9M | Buy |
502,008
+28,764
| +6% | +$1.37M | 0.01% | 1397 |
|
|
2022
Q2 | $18.3M | Buy |
473,244
+225,868
| +91% | +$8.74M | ﹤0.01% | 1578 |
|
|
2022
Q1 | $14.2M | Sell |
247,376
-2,232
| -0.9% | -$128K | ﹤0.01% | 1882 |
|
|
2021
Q4 | $19.9M | Buy |
249,608
+8,129
| +3% | +$648K | ﹤0.01% | 1727 |
|
|
2021
Q3 | $21M | Buy |
241,479
+26,304
| +12% | +$2.29M | ﹤0.01% | 1704 |
|
|
2021
Q2 | $27.7M | Buy |
215,175
+43,707
| +25% | +$5.63M | 0.01% | 1545 |
|
|
2021
Q1 | $13.7M | Sell |
171,468
-30,496
| -15% | -$2.44M | ﹤0.01% | 1917 |
|
|
2020
Q4 | $16.5M | Buy |
201,964
+56,398
| +39% | +$4.6M | ﹤0.01% | 1739 |
|
|
2020
Q3 | $3.58M | Buy |
145,566
+62,922
| +76% | +$1.55M | ﹤0.01% | 2387 |
|
|
2020
Q2 | $2.31M | Buy |
82,644
+60,223
| +269% | +$1.69M | ﹤0.01% | 2592 |
|
|
2020
Q1 | $403K | Buy |
+22,421
| New | +$403K | ﹤0.01% | 3475 |
|